MAM
SUPN icon

Mystic Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Mystic Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.33M Hold
25,700
– – 0.31% 81
2025
Q4 		$1.28M Hold
25,700
– – 0.29% 84
2025
Q3 		$1.23M Hold
25,700
– – 0.28% 85
2025
Q2 		$810K Sell
25,700
-2,300
-8% -$73.7K 0.2% 105
2025
Q1 		$917K Sell
28,000
-200
-0.7% -$7.09K 0.24% 95
2024
Q4 		$1.02M Sell
28,200
-40
-0.1% -$1.41K 0.27% 87
2024
Q3 		$881K Buy
28,240
+300
+1% +$9.36K 0.33% 80
2024
Q2 		$747K Sell
27,940
-1,300
-4% -$37.7K 0.3% 83
2024
Q1 		$997K Sell
29,240
-100
-0.3% -$2.98K 0.41% 73
2023
Q4 		$849K Sell
29,340
-500
-2% -$13.3K 0.41% 75
2023
Q3 		$823K Buy
29,840
+500
+2% +$15.2K 0.46% 72
2023
Q2 		$882K Sell
29,340
-1,400
-5% -$49K 0.47% 72
2023
Q1 		$1.11M Hold
30,740
– – 0.61% 59
2022
Q4 		$1.1M Sell
30,740
-100
-0.3% -$3.48K 0.62% 59
2022
Q3 		$1.04M Sell
30,840
-1,750
-5% -$56.9K 0.67% 54
2022
Q2 		$942K Sell
32,590
-500
-2% -$14.3K 0.57% 62
2022
Q1 		$1.07M Buy
33,090
+1,000
+3% +$30.7K 0.57% 62
2021
Q4 		$935K Buy
+32,090
New +$974K 0.44% 71

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mystic Asset Management's SUPN Position: Q1 2026 in Review

Mystic Asset Management held its Supernus Pharmaceuticals (SUPN) position steady in Q1 2026 at 25,700 shares worth $1.33M. The position accounts for 0.31% of the portfolio, ranked #81.

Mystic Asset Management first reported a position in SUPN in Q4 2021 and has held it in 18 quarters since. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Mystic Asset Management held 25,700 shares of Supernus Pharmaceuticals worth $1.33M as of Q1 2026.
  • Mystic Asset Management left its Supernus Pharmaceuticals share count unchanged in Q1 2026.
  • Supernus Pharmaceuticals made up 0.31% of Mystic Asset Management's portfolio in Q1 2026, its #81 holding.
  • Mystic Asset Management first reported a position in Supernus Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Mystic Asset Management's 13F filing for Q1 2026, filed 8 May 2026.